• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE EM2400 DY DISPLAY (2400-DY)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE EM2400 DY DISPLAY (2400-DY) Back to Search Results
Model Number 2400DY
Device Problem Use of Device Problem (1670)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Manufacturer Narrative
This issue was resolved through assistance provided by baxter technical support (bts).Based on the customer report and troubleshooting performed by bts, this event was determined to be use error.The exactamix compounder operator manual warns that patient harm may occur if corresponding source container barcodes are not scanned for verification during compounder set-up (i.E.Unattached or unrelated barcodes are scanned).The exactamix compounder operator manual also instructs the user to call bts for any assistance.(b)(4).
 
Event Description
The customer reported they had intentionally entered trophamine 10% in a tpn order and then hung premasol 10% on the exactamix compounder.During troubleshooting, baxter technical support (bts) discovered the customer had been ordering, within abacus order entry software, trophamine 10% for tpn orders containing premasol 10% and that the exactamix compounder did not have premasol 10% available as a selection.Since the amino acid concentration of 10% is the same for both products, the patient would receive the correct amount of amino acids.However, these two products have different calcium phosphate solubilities.Abacus software provides calcium phosphate solubility curves, based on the product being used, which allows the user to determine the potential for calcium phosphate precipitation in a given tpn order.Entering trophamine 10% but then hanging premasol 10% makes the calcium phosphate solubility curve data incorrect for the product actually being used.The use of incorrect calcium phosphate solubility curve data could lead to precipitation in the finished tpn.The tpn bag prepared with this configuration was released and used on a patient.However, no patient injury or adverse events were reported in relation to this event.Bts helped the customer properly set up premasol 10% in both the exactamix compounder and the abacus software.No additional information is available.Report 9 of 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EM2400 DY DISPLAY (2400-DY)
Type of Device
EM2400 DY DISPLAY (2400-DY)
Manufacturer (Section D)
BAXTER HEALTHCARE
14445 grasslands drive
englewood CO 80112
Manufacturer (Section G)
BAXTER HEALTHCARE
14445 grasslands drive
englewood CO 80112
Manufacturer Contact
phone vang
9540 s maroon circle
# 400
englewood, CO 80112
3037846639
MDR Report Key5488089
MDR Text Key39940600
Report Number1419106-2016-00146
Device Sequence Number1
Product Code NEP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 03/08/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/08/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number2400DY
Device Catalogue Number2400DY
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/09/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-